Editorial: BCG treatment of malignant melanoma.
D000951:Antigens, Neoplasm; D001500:BCG Vaccine / Q000009:adverse effects*; D006801:Humans; D007271:Injections, Intradermal; D008545:Melanoma / Q000276:immunology / Q000628:therapy*
D000951:Antigens, Neoplasm; D001500:BCG Vaccine